Literature DB >> 33428596

Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer.

Yuan Huang1, Xiaowei Wang2, Yiran Zheng3, Wei Chen4, Yabing Zheng1, Guangliang Li1, Weiyang Lou5, Xiaojia Wang1.   

Abstract

The aim of this study was to establish a novel competing endogenous RNA (ceRNA) network able to predict prognosis in patients with triple-negative breast cancer (TNBC). Differential gene expression analysis was performed using the GEO2R tool. Enrichr and STRING were used to conduct protein-protein interaction and pathway enrichment analyses, respectively. Upstream lncRNAs and miRNAs were identified using miRNet and mirTarBase, respectively. Prognostic values, expression, and correlational relationships of mRNAs, lncRNAs, and miRNAs were examined using GEPIA, starBase, and Kaplan-Meier plotter. It total, 860 upregulated and 622 downregulated differentially expressed mRNAs were identified in TNBC. Ten overexpressed and two underexpressed hub genes were screened. Next, 10 key miRNAs upstream of these key hub genes were predicted, of which six upregulated miRNAs were significantly associated with poor prognosis and four downregulated miRNAs were associated with good prognosis in TNBC. NEAT1 and MAL2 were selected as key lncRNAs. An mRNA-miRNA-lncRNA network in TNBC was constructed. Thus, we successfully established a novel mRNA-miRNA-lncRNA regulatory network, each component of which is prognostic for TNBC.

Entities:  

Keywords:  biomarker; competing endogenous RNA; prognosis; triple-negative breast cancer

Mesh:

Substances:

Year:  2021        PMID: 33428596      PMCID: PMC7835059          DOI: 10.18632/aging.202254

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  59 in total

Review 1.  Triple-negative breast cancer.

Authors:  William D Foulkes; Ian E Smith; Jorge S Reis-Filho
Journal:  N Engl J Med       Date:  2010-11-11       Impact factor: 91.245

2.  lncRNA ZFPM2-AS1 promotes proliferation via miR-18b-5p/VMA21 axis in lung adenocarcinoma.

Authors:  Min Xue; Weimin Tao; Suyun Yu; Zhijun Yan; Qing Peng; Fan Jiang; Xiwen Gao
Journal:  J Cell Biochem       Date:  2019-07-11       Impact factor: 4.429

Review 3.  IGF1 receptor signaling pathways.

Authors:  Fumihiko Hakuno; Shin-Ichiro Takahashi
Journal:  J Mol Endocrinol       Date:  2018-03-13       Impact factor: 5.098

Review 4.  ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer.

Authors:  Rinath Jeselsohn; Gilles Buchwalter; Carmine De Angelis; Myles Brown; Rachel Schiff
Journal:  Nat Rev Clin Oncol       Date:  2015-06-30       Impact factor: 66.675

5.  MiR-98-5p regulates proliferation and metastasis of MCF-7 breast cancer cells by targeting Gab2.

Authors:  X-Y Shi; H Wang; W Wang; Y-H Gu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-04       Impact factor: 3.507

6.  MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome.

Authors:  Jennifer A Byrne; Sanaz Maleki; Jayne R Hardy; Brian S Gloss; Rajmohan Murali; James P Scurry; Susan Fanayan; Catherine Emmanuel; Neville F Hacker; Robert L Sutherland; Anna Defazio; Philippa M O'Brien
Journal:  BMC Cancer       Date:  2010-09-17       Impact factor: 4.430

Review 7.  An overview of triple-negative breast cancer.

Authors:  Pankaj Kumar; Rupali Aggarwal
Journal:  Arch Gynecol Obstet       Date:  2015-09-04       Impact factor: 2.344

8.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.

Authors:  Zefang Tang; Chenwei Li; Boxi Kang; Ge Gao; Cheng Li; Zemin Zhang
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

9.  CCNA2 acts as a novel biomarker in regulating the growth and apoptosis of colorectal cancer.

Authors:  Yaqi Gan; Yimin Li; Tong Li; Guang Shu; Gang Yin
Journal:  Cancer Manag Res       Date:  2018-10-31       Impact factor: 3.989

10.  Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma.

Authors:  Shu Dong; Fei Huang; Hao Zhang; Qiwen Chen
Journal:  Biosci Rep       Date:  2019-02-26       Impact factor: 3.840

View more
  8 in total

Review 1.  Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer.

Authors:  Navid Sobhani; Richard Chahwan; Raheleh Roudi; Rachel Morris; Stefano Volinia; Dafei Chai; Alberto D'Angelo; Daniele Generali
Journal:  Cancers (Basel)       Date:  2022-06-15       Impact factor: 6.575

2.  Assessment of MicroRNAs Associated with Tumor Purity by Random Forest Regression.

Authors:  Dong-Yeon Nam; Je-Keun Rhee
Journal:  Biology (Basel)       Date:  2022-05-21

3.  NcRNAs-mediated P2RX1 expression correlates with clinical outcomes and immune infiltration in patients with breast invasive carcinoma.

Authors:  Yiyue Xu; Bing Zou; Bingjie Fan; Butuo Li; Jinming Yu; Linlin Wang; Jin Zhang
Journal:  Aging (Albany NY)       Date:  2022-05-18       Impact factor: 5.955

Review 4.  Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement.

Authors:  Jabeen Farheen; Narayan S Hosmane; Ruibo Zhao; Qingwei Zhao; M Zubair Iqbal; Xiangdong Kong
Journal:  Mater Today Bio       Date:  2022-10-04

5.  MIMRDA: A Method Incorporating the miRNA and mRNA Expression Profiles for Predicting miRNA-Disease Associations to Identify Key miRNAs (microRNAs).

Authors:  Xianbin Li; Hannan Ai; Bizhou Li; Chaohui Zhang; Fanmei Meng; Yuncan Ai
Journal:  Front Genet       Date:  2022-01-27       Impact factor: 4.599

6.  ADAM metallopeptidase domain 12 overexpression correlates with prognosis and immune cell infiltration in clear cell renal cell carcinoma.

Authors:  Junjie Gao; Dandan Yang; Haonan Xu; Kunpeng Yang; Jia Ma; Jun Xia; Xueshan Pan
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

7.  Long non-coding RNA (LncRNA) CASC9/microRNA(miR)-590-3p/sine oculis homeobox 1 (SIX1)/NF-κB axis promotes proliferation and migration in breast cancer.

Authors:  Jingzhi Chang; Yuxia Zhang; Xin Ye; Hui Guo; Kun Lu; Qing Liu; Yli Guo
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  Differential expression profile of mRNAs, lncRNAs, and circRNAs reveals potential molecular mechanism in breast cancer.

Authors:  Yuan Li; Chiseng Lei; Yude Xie; Jie Zhang; Ningxia Wang; Weili He; Shaohua Qu
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.